Ocumetics Technology (TSXV:OTC) Debt-to-Equity : 3.54 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Ocumetics Technology Debt-to-Equity?

Ocumetics Technology's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was C$0.00 Mil. Ocumetics Technology's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was C$0.32 Mil. Ocumetics Technology's Total Stockholders Equity for the quarter that ended in Dec. 2023 was C$0.09 Mil. Ocumetics Technology's debt to equity for the quarter that ended in Dec. 2023 was 3.54.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Ocumetics Technology's Debt-to-Equity or its related term are showing as below:

TSXV:OTC' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.35 Med: 1.94 Max: 3.54
Current: 3.54

During the past 4 years, the highest Debt-to-Equity Ratio of Ocumetics Technology was 3.54. The lowest was 0.35. And the median was 1.94.

TSXV:OTC's Debt-to-Equity is ranked worse than
97.72% of 702 companies
in the Medical Devices & Instruments industry
Industry Median: 0.22 vs TSXV:OTC: 3.54

Ocumetics Technology Debt-to-Equity Historical Data

The historical data trend for Ocumetics Technology's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ocumetics Technology Debt-to-Equity Chart

Ocumetics Technology Annual Data

Trend

Jul20

Jul21

Dec22

Dec23

Debt-to-Equity

N/A

0.35

3.54

Ocumetics Technology Quarterly Data
	Jul20	Jul21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial						0.35	-	-	-	3.54

Competitive Comparison of Ocumetics Technology's Debt-to-Equity

For the Medical Instruments & Supplies subindustry, Ocumetics Technology's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ocumetics Technology's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ocumetics Technology's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Ocumetics Technology's Debt-to-Equity falls into.

Ocumetics Technology Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Ocumetics Technology's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0.322)	/	0.091
	=	3.54

Ocumetics Technology's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0.322)	/	0.091
	=	3.54

Ocumetics Technology (TSXV:OTC) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Ocumetics Technology Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Ocumetics Technology's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Ocumetics Technology (TSXV:OTC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ocumetics Technology Corp (TSXV:OTC) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

OTCFF:USA

Address

639 - 5th Avenue S.W., Suite 1250, Calgary, AB, CAN, T2P 0M9

Website

https://www.ocumetics.com

Ocumetics Technology Corp is a Canadian-based research and product development company. The company is engaged in developing an accommodating intraocular lens to eliminate the need for corrective lenses, especially for people over 45 years of age.

Executives

Roger Jewett

Director, Senior Officer

Ocumetics Technology (TSXV:OTC) Headlines

No Headlines